Comparing the projected cost per HbA1c reduction of exenatide QW versus liraglutide 1.8 mg for the treatment of type 2 diabetes mellitus using alternate data sources
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1456
https://www.valueinhealthjournal.com/article/S1098-3015(14)01507-1/fulltext
Title :
Comparing the projected cost per HbA1c reduction of exenatide QW versus liraglutide 1.8 mg for the treatment of type 2 diabetes mellitus using alternate data sources
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01507-1&doi=10.1016/j.jval.2014.03.1456
First page :
A250
Section Title :
Diabetes/Endocrine Disorders I
Open access? :
No
Section Order :
940